M1 Kliniken AG (M12.DE)
EUR 15.55
(-4.01%)
EUR 15.55
(-4.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.91 Million | 21.02 Million | 15.65 Million | 9.38 Million | -3.52 Million | 2.86 Million |
| Net Income | 10.27 Million | 4.31 Million | 8.9 Million | 6.82 Million | 9.72 Million | 6.61 Million |
| Depreciation & Amortization | 5.31 Million | 5.86 Million | 5.64 Million | 4.48 Million | 3.4 Million | 710.77 Thousand |
| Deferred income taxes | -1.23 Million | 776.03 Thousand | 791.56 Thousand | 400.1 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -8.84 Million | 7.36 Million | -3.63 Million | 802.25 Thousand | -12.03 Million | -5.4 Million |
| Other non-cash items | 26.03 Million | 11.2 Million | 8.11 Million | 8.16 Million | -4.62 Million | 940.81 Thousand |
| Investing Cash Flow | -11.35 Million | -1.77 Million | -266.35 Thousand | 2.93 Million | -5.18 Million | -1.94 Million |
| Investments in PPE | -1 Million | -1.77 Million | -1.33 Million | -1.44 Million | -1.34 Million | -2.09 Million |
| Acquisitions | 49.42 Thousand | 73.47 Thousand | 1.25 Million | 2.2 Million | 333.32 Thousand | 7074.61 |
| Investment purchases | -10.39 Million | -71.47 Thousand | -192.24 Thousand | - | -4.17 Million | -1.26 Million |
| Sales/Maturities of investments | - | -46.26 Thousand | - | 2.18 Million | 2.27 Million | 1.25 Million |
| Other Investing Activities | 1.35 Million | 46.26 Thousand | 5250.00 | -399.00 | -2.27 Million | 155.78 Thousand |
| Financing Cash Flow | -13.92 Million | -21.96 Million | 4.53 Million | 712.75 Thousand | -7.57 Million | 9.77 Million |
| Debt repayment | -3.62 Million | -13.4 Million | -4.21 Million | -4.04 Million | -65.25 Thousand | -65.25 Thousand |
| Dividends payments | -1.98 Million | -1.82 Million | -1.65 Million | -128.51 Thousand | -5.25 Million | -4.95 Million |
| Common Stock Repurchased | -24.74 Million | -2.14 Million | -9.75 Million | - | - | -14.73 Million |
| Common Stock Issuance | 7.57 Million | 15.95 Million | 14.48 Million | - | - | 14.79 Million |
| Other Financing Activities | 13.01 Million | -20.54 Million | 5.68 Million | 4.88 Million | -2.26 Million | 14.72 Million |
| Accounts receivables | 5.17 Million | -4.37 Million | -15.54 Million | 5.91 Million | -19.29 Million | -5.4 Million |
| Accounts payables | - | - | 15.54 Million | 2.18 Million | 19.29 Million | 3.8 Million |
| Inventory | -17.17 Million | 7.59 Million | 7.13 Million | -4.51 Million | -115.47 Thousand | 6013.00 |
| Other working capital | 3.15 Million | 4.14 Million | -10.77 Million | -2.78 Million | -11.91 Million | -3.8 Million |
| Cash at beginning of period | 35.14 Million | 37.86 Million | 21.95 Million | 9.09 Million | 25.38 Million | 14.68 Million |
| Cash at end of period | 22.38 Million | 35.14 Million | 37.86 Million | 21.95 Million | 9.09 Million | 25.38 Million |
| Capital Expenditure | -1 Million | -1.77 Million | -1.33 Million | -1.44 Million | -1.34 Million | -2.09 Million |
| Effect of forex changes on cash | 72.46 Thousand | -5935.00 | -13.67 Thousand | -4.17 Million | -1.00 | -1.00 |
| Net cash flow / Change in cash | -12.76 Million | -2.72 Million | 15.9 Million | 12.86 Million | -16.28 Million | 10.69 Million |
| Free Cash Flow | 7.9 Million | 19.25 Million | 14.32 Million | 7.93 Million | -4.86 Million | 764.51 Thousand |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.89 Million | 10.27 Million | 6.85 Million | 3.41 Million | 4.31 Million | 2.93 Million |
| Depreciation & Amortization | 2.49 Million | 5.31 Million | 2.64 Million | 2.66 Million | 5.86 Million | 3.17 Million |
| Deferred income taxes | - | -1.23 Million | -1.23 Million | - | 776.03 Thousand | 776.03 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.12 Million | -8.84 Million | -2.52 Million | -6.32 Million | 7.36 Million | 2.48 Million |
| Other non-cash items | -2.97 Million | 26.03 Million | 6.02 Million | 14.34 Million | 11.2 Million | 8.23 Million |
| Investing Cash Flow | -12.45 Million | -11.35 Million | -2.85 Million | -8.5 Million | -1.77 Million | 6.95 Million |
| Investments in PPE | -59.41 Thousand | -1 Million | -465.22 Thousand | -544.28 Thousand | -1.77 Million | -918.66 Thousand |
| Acquisitions | 6000.00 | 49.42 Thousand | 96.98 Thousand | -47.56 Thousand | 73.47 Thousand | 43.47 Thousand |
| Investment purchases | -12.16 Million | -10.39 Million | -2.48 Million | -7.91 Million | -71.47 Thousand | 7.83 Million |
| Sales/Maturities of investments | - | - | - | 7.92 Million | -46.26 Thousand | -7.98 Million |
| Other Investing Activities | -12.39 Million | 1.35 Million | -1.03 Million | -7.87 Million | 46.26 Thousand | 7.98 Million |
| Financing Cash Flow | -17.48 Million | -13.92 Million | -8.14 Million | -5.77 Million | -21.96 Million | -8.57 Million |
| Debt repayment | -3.54 Million | -3.62 Million | -625 Thousand | -3 Million | -13.4 Million | -2.24 Million |
| Dividends payments | - | -1.98 Million | -1.98 Million | - | -1.82 Million | -1.82 Million |
| Common Stock Repurchased | -13.16 Million | -24.74 Million | -24.08 Million | -655.58 Thousand | -2.14 Million | -2.14 Million |
| Common Stock Issuance | - | 7.57 Million | 7.57 Million | - | 15.95 Million | 4.63 Million |
| Other Financing Activities | -777.82 Thousand | 13.01 Million | 13.01 Million | -298.37 Thousand | -20.54 Million | 8.55 Million |
| Accounts receivables | -1.79 Million | 5.17 Million | 17.93 Million | -12.75 Million | -4.37 Million | 1.62 Million |
| Accounts payables | -6.65 Million | - | - | 5.66 Million | - | -2.3 Million |
| Inventory | 8.06 Million | -17.17 Million | -17.91 Million | 735.16 Thousand | 7.59 Million | -2.14 Million |
| Other working capital | -1.14 Million | 3.15 Million | 3.12 Million | 25.54 Thousand | 4.14 Million | 5.31 Million |
| Cash at beginning of period | 22.38 Million | 35.14 Million | 23.3 Million | 35.14 Million | 37.86 Million | 26.02 Million |
| Cash at end of period | 3.45 Million | 22.38 Million | 22.38 Million | 23.3 Million | 35.14 Million | 35.14 Million |
| Capital Expenditure | -59.41 Thousand | -1 Million | -465.22 Thousand | -544.28 Thousand | -1.77 Million | -918.66 Thousand |
| Effect of forex changes on cash | -6551.00 | 72.46 Thousand | 54.26 Thousand | 18.19 Thousand | -5935.00 | -9059.00 |
| Net cash flow / Change in cash | -18.93 Million | -12.76 Million | -919.09 Thousand | -11.84 Million | -2.72 Million | 9.12 Million |
| Free Cash Flow | 14.48 Million | 7.9 Million | 6.04 Million | 1.86 Million | 19.25 Million | 9.82 Million |
ACHYUT
GMALF
KCRD
AHL-PE
FEDU
CAOHF